Lowenstein has advised Matinas in the sale of Matinas BioPharma Nanotechnologies to Azurity Pharmaceuticals. Matinas BioPharma has entered into a definitive stock purchase agreement to sell...
Azurity Pharmaceuticals to Acquire Matinas BioPharma Nanotechnologies
Matinas BioPharma and GH Power Announce Business Combination to Create NYSE-listed Clean Energy and Critical Minerals Company
Lowenstein Sandler LLP has represented Matinas BioPharma Holdings, Inc. in its business combination agreement with GH Power, Inc. Matinas BioPharma Holdings, Inc., a biopharmaceutical company listed...
Miller Environmental Group Acquires Central Ohio Oil Company
Lowenstein Sandler has advised Coalesce Capital portfolio company Miller Environmental Group. Miller Environmental Group, a portfolio company of Coalesce Capital, has acquired all the issued and...
Sonnet BioTherapeutics Completes Business Combination with Hyperliquid Strategies
Lowenstein Sandler has advised Sonnet BioTherapeutics Holdings. Greenberg Traurig has advised Hyperliquid Strategies Inc. Sonnet BioTherapeutics Holdings, an oncology-focused biotechnology company, has completed its business combination...
Salute Acquires Northshore to Enhance Data Center Sustainability Services
Lowenstein Sandler has advised Salute on the deal. Salute, a global provider of comprehensive data center services, has completed the acquisition of Northshore, a global engineering...
Sonnet BioTherapeutics and Rorschach I LLC Announce $888 Million HYPE Cryptocurrency Treasury Reserve Strategy
Lowenstein Sandler LLP has advised Sonnet BioTherapeutics, Inc. Greenberg Traurig, LLP has represented Rorschach I LLC. Sonnet BioTherapeutics, Inc. has entered into a definitive agreement to...
PerkinElmer’s Acquisition of Project Farma
Lowenstein Sandler represented PerkinElmer in the transaction. PerkinElmer, a global leader in analytical solutions and specialized services for (bio)pharma, applied and food markets, announced the acquisition...
Indorama Ventures’ Acquisition of KEMELIX and FLOWSOLVE
Lowenstein Sandler represented Indorama Ventures in the transaction. Indorama Ventures (BKK: IVL), a global leader in sustainable chemicals, has entered into an agreement by its Indovinya...
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
First Wave BioPharma’s Acquisition of ImmunogenX
Lowenstein represented First Wave BioPharma, Inc. in the transaction. First Wave BioPharma, Inc. (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic...
Timber Pharmaceuticals’ Chapter 11 and Asset Sale to Leo Pharma
Lowenstein Sandler represented Timber Pharmaceuticals, Inc. in the transaction. Timber Pharmaceuticals, Inc. (NYSE: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for...
Static Media’s Partnership with Novacap Partners
Lowenstein represented Static Media, while Foley & Lardner LLP represented Novacap in the deal. Static Media announced its partnership with Novacap, a leading North American private equity...